A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY of two formulations IN THE MANAGEMENT OF AMAVATA WITH SPECIAL REFERENCE TO RHEUMATOID ARTHRITIS

A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF SHOOLAPRSHAMANA CHOORNA AND HINGUTRIGUNA TAILA CAPSULE IN THE MANAGEMENT OF AMAVATA WITH SPECIAL REFERENCE TO RHEUMATOID ARTHRITIS

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046235

Enrollment

105

Registered

2022-10-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M049- Autoinflammatory syndrome, unspecified Health Condition 2: M049- Autoinflammatory syndrome, unspecified Health Condition 3: M368- Systemic disorders of connective tissue in other diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS diagnosed as having Amavata on the basis of signs and symptoms that are typically diagnosed as classical symptoms and Rheumatoid Arthritis on basis of ACR CRITERIA FOR DIAGNOSING RHEUMATOID ARTHRITIS

Exclusion criteria

Exclusion criteria: patients suffering from complications of Aamavata Juveline RA Septic arthritis Rheumatic Heart Disease RA with involvement of other organs.

Design outcomes

Primary

Measure	Time frame
Subjective parameters Sandhi shoola Sandhi shotha Sparshasahatva Stabdata Angamarda Aruchi Alasya Objective parameters C-RP ESR Anti-CCP RA factor Assesment will be done on Pain Swelling Morning stiffness Tenderness Fever ESR score C-RP score DAS 28 score Disability Index Quality of Life Index SF36 by adapting standard methods of scoring.Timepoint: OBJECTIVE PARAMETERS C-RP ESR RA factor Anti-CCP ASSESSMENT CRITERIA Assessment will be made for clinical signs and symptoms & investigations Statistical analysis package of version 20 will be done by using chi-square/Fisher’s test for subjective parameters & students t test for objective parameters. SAMPLE SIZE 120PATIENTS 60 Patients in each group and treatment for 1month with follow up of 15days	—

Measure

Time frame

Subjective parameters Sandhi shoola Sandhi shotha Sparshasahatva Stabdata Angamarda Aruchi Alasya Objective parameters C-RP ESR Anti-CCP RA factor Assesment will be done on Pain Swelling Morning stiffness Tenderness Fever ESR score C-RP score DAS 28 score Disability Index Quality of Life Index SF36 by adapting standard methods of scoring.Timepoint: OBJECTIVE PARAMETERS C-RP ESR RA factor Anti-CCP ASSESSMENT CRITERIA Assessment will be made for clinical signs and symptoms & investigations Statistical analysis package of version 20 will be done by using chi-square/Fisher’s test for subjective parameters & students t test for objective parameters. SAMPLE SIZE 120PATIENTS 60 Patients in each group and treatment for 1month with follow up of 15days

—

Secondary

Measure	Time frame
Incidence of Amavata as per Age Sex Lifestyle will be made in Parul Institute of Ayurveda,Parul University Vadodara,GujaratTimepoint: 6months	—

Countries

India

Contacts

Public ContactDr Seeta MBiradar

Parul Institute of Ayurveda

shivani.gavande21706@paruluniversity.ac.in9420205131

Outcome results